Development and characterization of SARS-CoV-2 variant-neutralizing monoclonal antibodies

被引:2
作者
Qiu, Hongyu [1 ]
Yuan, Xin-Yong [1 ]
Cabral, Teresa [1 ]
Manguiat, Kathy [1 ]
Robinson, Alyssia [1 ]
Wood, Heidi [1 ]
Grant, Chris [1 ]
McQueen, Peter [1 ]
Westmacott, Garrett [1 ]
Beniac, Daniel R. [1 ]
Lin, Lisa [1 ]
Carpenter, Michael [1 ]
Kobasa, Darwyn [1 ]
Grafenhan, Tom [1 ,2 ]
机构
[1] Publ Hlth Agcy Canada, Natl Microbiol Lab, 1015 Arlington St, Winnipeg, MB R3E 3R2, Canada
[2] Univ Wurzburg, Med Fac, Core Unit Syst Med SysMed, Josef Schneider Str 2, D-97080 Wurzburg, Germany
关键词
SARS-CoV-2; Broad-spectrum neutralizing mAbs; Variant of concern (VOC); PRNT; MUTATIONS; SPIKE;
D O I
10.1016/j.antiviral.2021.105206
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Vaccination and administration of monoclonal antibody cocktails are effective tools to control the progression of infectious diseases and to terminate pandemics such as COVID-19. However, the emergence of SARS-CoV-2 mutants with enhanced transmissibility and altered antigenicity requires broad-spectrum therapies. Here we developed a panel of SARS-CoV-2 specific mouse monoclonal antibodies (mAbs), and characterized them based on ELISA, Western immunoblot, isotyping, and virus neutralization. Six neutralizing mAbs that exhibited high affinity binding to SARS-CoV-2 spike protein were identified, and their amino acid sequences were determined by mass spectrometry. Functional assays confirmed that three mAbs, F461G11, F461G15, and F461G16 neutralized four variants of concern (VOC): B.1.1.7 (alpha), B.1.351 (beta), P.1 (gamma) and B.1.617.2 (delta) These mAbs are promising candidates for COVID-19 therapy, and understanding their interactions with virus spike protein should support further vaccine and antibody development.
引用
收藏
页数:8
相关论文
共 55 条
[21]   The Architecture of SARS-CoV-2 Transcriptome [J].
Kim, Dongwan ;
Lee, Joo-Yeon ;
Yang, Jeong-Sun ;
Kim, Jun Won ;
Kim, V. Narry ;
Chang, Hyeshik .
CELL, 2020, 181 (04) :914-+
[22]   SARS-CoV-2 vaccines in development [J].
Krammer, Florian .
NATURE, 2020, 586 (7830) :516-527
[23]   Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020 [J].
Leung, Kathy ;
Shum, Marcus H. H. ;
Leung, Gabriel M. ;
Lam, Tommy T. Y. ;
Wu, Joseph T. .
EUROSURVEILLANCE, 2021, 26 (01) :15-21
[24]   The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity [J].
Li, Qianqian ;
Wu, Jiajing ;
Nie, Jianhui ;
Zhang, Li ;
Hao, Huan ;
Liu, Shuo ;
Zhao, Chenyan ;
Zhang, Qi ;
Liu, Huan ;
Nie, Lingling ;
Qin, Haiyang ;
Wang, Meng ;
Lu, Qiong ;
Li, Xiaoyu ;
Sun, Qiyu ;
Liu, Junkai ;
Zhang, Linqi ;
Li, Xuguang ;
Huang, Weijin ;
Wang, Youchun .
CELL, 2020, 182 (05) :1284-+
[25]   Predictors ofCOVID-19 severity: A literature review [J].
Marin, Benjamin Gallo ;
Aghagoli, Ghazal ;
Lavine, Katya ;
Yang, Lanbo ;
Siff, Emily J. ;
Chiang, Silvia S. ;
Salazar-Mather, Thais P. ;
Dumenco, Luba ;
Savaria, Michael C. ;
Aung, Su N. ;
Flanigan, Timothy ;
Michelow, Ian C. .
REVIEWS IN MEDICAL VIROLOGY, 2021, 31 (01) :1-10
[26]   Intestinal proteomic analysis of a novel non-human primate model of experimental colitis reveals signatures of mitochondrial and metabolic dysfunction [J].
McQueen, Peter ;
Busman-Sahay, Kathleen ;
Rieder, Florian ;
Noel-Romas, Laura ;
McCorrister, Stuart ;
Westmacott, Garrett ;
Estes, Jacob D. ;
Burgener, Adam .
MUCOSAL IMMUNOLOGY, 2019, 12 (06) :1327-1335
[27]   Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors [J].
Meyerowitz, Eric A. ;
Richterman, Aaron ;
Gandhi, Rajesh T. ;
Sax, Paul E. .
ANNALS OF INTERNAL MEDICINE, 2021, 174 (01) :69-+
[28]   Complete De Novo Assembly of Monoclonal Antibody Sequences [J].
Ngoc Hieu Tran ;
Rahman, M. Ziaur ;
He, Lin ;
Xin, Lei ;
Shan, Baozhen ;
Li, Ming .
SCIENTIFIC REPORTS, 2016, 6
[29]   Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy [J].
Onder, Graziano ;
Rezza, Giovanni ;
Brusaferro, Silvio .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (18) :1775-1776
[30]   Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen [J].
Pallesen, Jesper ;
Wang, Nianshuang ;
Corbett, Kizzmekia S. ;
Wrapp, Daniel ;
Kirchdoerfer, Robert N. ;
Turner, Hannah L. ;
Cottrell, Christopher A. ;
Becker, Michelle M. ;
Wang, Lingshu ;
Shi, Wei ;
Kong, Wing-Pui ;
Andres, Erica L. ;
Kettenbach, Arminja N. ;
Denison, Mark R. ;
Chappell, James D. ;
Graham, Barney S. ;
Ward, Andrew B. ;
McLellan, Jason S. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (35) :E7348-E7357